If you or your child takes generic Adderall XR and just heard the word "recall," here's what you actually need to know before you do anything else: this is not a recall of the drug Adderall XR in general. It's a recall of one specific lot, from one manufacturer, in one strength and bottle size. The problem is serious for the people affected — capsules labeled to last half a day that actually wear off in a few hours — but the scope is small and specific, and checking whether it applies to you takes about 30 seconds.
Most coverage of FDA recalls reads like a copy-pasted government notice: drug name, lot number, "consult your doctor," done. We're doing this differently. Below, you'll find the exact lot number to check against your own bottle, a plain-English explanation of what actually happens in your body when an extended-release capsule turns out to be immediate-release, and a clear plan for what to do whether or not your bottle matches — including how this recall fits into the stimulant shortage that's made switching medications harder than it used to be.
Check Your Bottle in 30 Seconds
Grab your prescription bottle and compare it against these four details. If all four match, you have an affected bottle.
Recalled Product Details
All four must match for your bottle to be part of this recall
The lot number is printed on the bottle label, usually near the expiration date, and often abbreviated "LOT" or "L." The NDC number is the 10 or 11-digit code also on the label, sometimes broken up with dashes. The medication itself is labeled as dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules, distributed by Lannett Company, Inc., in 100-count bottles.
If your bottle doesn't match this lot number, it is not part of this recall — even if it's the same drug, strength, and manufacturer. Other lots of Lannett's 5 mg Adderall XR, and all other strengths, are not affected. Don't stop a working medication over a recall that doesn't apply to your specific bottle.
What Actually Happened
Lannett Company initiated this recall after discovering that bottles labeled as extended-release amphetamine mixed salts capsules, 5 mg, actually contained capsules filled only with immediate-release pellets. In extended-release stimulant capsules, the inside of the capsule normally contains a mix of pellets: some coated to dissolve right away, others coated to dissolve gradually over several hours, which is what gives ER products their long, steady coverage. When a batch ends up filled entirely with the immediate-release type of pellet, the capsule looks identical from the outside but behaves completely differently once swallowed.
Lannett notified pharmacies and distributors directly by letter rather than issuing a public press release, which is standard for a recall of this size and classification. That's also why you may not have heard about it through typical news channels — the notification process for a narrow, single-lot recall like this one runs through the supply chain rather than the evening news.
What an ER-Labeled, IR-Filled Capsule Actually Does to Your Day
This is the part that actually matters for how you feel, not just the regulatory description. Extended-release amphetamine capsules are designed to release medication gradually so that a single morning dose covers roughly 10 to 12 hours. Immediate-release capsules release everything at once and typically last 4 to 6 hours before wearing off.
If your capsule was mislabeled, taking it at 8 a.m. expecting all-day coverage would actually give you a dose that behaves like an immediate-release tablet — a quicker onset, followed by symptoms returning by early afternoon instead of staying controlled into the evening. For some patients that shows up as a return of inattention or restlessness at work or school. For others, it can show up as an unexpectedly sharp comedown, sometimes described as feeling irritable, foggy, or fatigued once the medication's effect drops off faster than expected.
Why this matters for you: If you've had an unusually rough afternoon lately — energy crashing hours earlier than normal, or ADHD symptoms coming back well before your next dose was due — and you take generic Adderall XR, it's worth checking your lot number today rather than assuming it's just a bad day.
Class I vs. Class II vs. Class III: What This Recall Actually Is
FDA recall classifications get thrown around loosely in a lot of recall coverage, so here's what each one actually means and where this recall lands.
| Class | What It Means | This Recall? |
|---|---|---|
| Class I | Reasonable probability of serious adverse health consequences or death | No |
| Class II | May cause temporary or medically reversible health consequences, or remote probability of serious harm | Yes — this is the classification issued |
| Class III | Unlikely to cause any adverse health consequence | No |
In plain terms: the FDA is treating this as a real problem worth pulling the product for, but not one expected to cause lasting harm for most patients. That distinction matters if you're trying to gauge how urgently to act — urgently enough to check today, but not a reason to panic if you took an affected dose a few days ago.
Lannett's Recent ADHD Medication Recall History
This isn't Lannett's first labeling-related recall in this drug category. Seeing the pattern helps put this specific recall in context.
| Date Initiated | Product | Issue | FDA Class |
|---|---|---|---|
| October 2024 | Lisdexamfetamine dimesylate 10 mg | Failed content uniformity specifications | Class II |
| August 2025 | Lisdexamfetamine dimesylate 40 mg | Bottles labeled 40 mg actually contained 30 mg capsules | Class II |
| August 2025 | Amphetamine mixed salts tablets, 10 mg | Bottle strength mislabeling; distributed in Ohio only | Class II |
| June 2026 | Amphetamine mixed salts extended-release capsules, 5 mg (this recall) | ER-labeled capsules contained only IR pellets | Class II |
None of these have been Class I recalls, and each affected a specific lot or strength rather than Lannett's entire ADHD product line. If you take a Lannett-manufactured stimulant regularly, it's a reasonable habit to glance at the lot number each time you pick up a refill, simply because this manufacturer has had more than one labeling-related recall in this category over the past two years.
What to Do If You Already Took a Mislabeled Dose
Don't panic, but don't drive if you feel off
If you notice your focus or alertness dropping earlier than usual, treat it the way you would any day your medication didn't work as expected — avoid driving or operating machinery if you feel impaired, foggy, or unusually fatigued.
Do not take an extra dose to compensate
If symptoms return in the afternoon, resist the urge to take another capsule on top of what you already took. Taking additional stimulant medication outside your prescribed schedule can cause its own problems, including sleep disruption and appetite suppression.
Note which bottle and approximately how many doses you took from it
Your pharmacist or prescriber may ask how many capsules from the affected lot you actually took, which helps them assess whether any follow-up is needed.
Report it if your reaction was significant
If you experienced a notable adverse reaction, report it to the FDA's MedWatch program and to Lannett Company directly. This helps the FDA track the real-world impact of the mislabeling beyond the lab-confirmed defect.
Decision Tree: What Should You Do Right Now?
Does your bottle's lot number match 25285401A?
Check the label next to the expiration date first
Stop using this bottle
Call your pharmacy today to arrange a replacement
Don't have a replacement lined up yet?
Ask your prescriber about a short-term bridge plan while you wait for stock
Your medication is not part of this recall
Continue your regimen as prescribed
Still noticing coverage issues?
That may be a separate dosing or shortage-related issue — talk to your prescriber
Either way
Keep the bottle and label until the issue is fully resolved, in case your pharmacy or prescriber needs to reference it
Step-by-Step: How to Respond to This Recall
Check your lot number against 25285401A
Do this before anything else. It takes less time than reading the rest of this article.
Call your dispensing pharmacy if it matches
Ask specifically for a replacement from an unaffected lot. Pharmacies that filled this lot should already have been notified, so you may not be the first patient to call about it.
Keep taking your medication as prescribed while you sort out the replacement
Don't stop a stimulant regimen abruptly on your own. If you're waiting on a replacement fill, talk to your prescriber about how to bridge the gap safely.
Ask whether your insurance requires anything extra for a recall-driven replacement
Most insurers and pharmacies process recall replacements without a new copay or prior authorization, but it's worth confirming, especially if your plan requires prior authorization for stimulants in general — see our Express Scripts prior authorization guide and Aetna prior authorization guide for what that process typically looks like.
If your pharmacy is out of replacement stock, check nearby options before waiting
Given the ongoing national stimulant shortage, some pharmacies may not have immediate replacement inventory. Our Adderall shortage guide covers current availability patterns and what to do when your usual pharmacy comes up empty.
Eligibility Comparison: Cost Help If You Need to Switch
If this recall pushes you toward a different manufacturer, strength, or pharmacy, it's worth knowing your cost options upfront. Because Adderall XR and its generics are decades-old and heavily genericized, there's no manufacturer income-based patient assistance program the way there is for many newer, expensive brand-name drugs — cost help here comes from discount cards, 340B clinics, and insurance coverage rules instead.
| Option | Insurance Required? | Income-Based? | Best For |
|---|---|---|---|
| GoodRx / SingleCare / Inside Rx discount cards | No — cannot combine with insurance | No | Uninsured or cash-paying patients switching pharmacies |
| State Medicaid | Medicaid enrollment required | Yes | Medicaid enrollees needing a formulary-covered alternative |
| 340B community health centers | No insurance required | Yes | Patients receiving care at a qualifying clinic |
| Commercial insurance formulary switch | Commercial insurance required | No | Insured patients whose plan covers an alternative manufacturer |
| Manufacturer patient assistance (Adderall XR generics) | N/A | Not applicable — no program exists | No one — stimulant generics generally aren't PAP-eligible |
Our GoodRx vs. Inside Rx comparison can help you find the lowest verified cash price at a nearby pharmacy if you end up needing to fill at a new location.
Income Limit Comparison for Assistance Options
Because there's no manufacturer PAP for this drug category, income-based help comes primarily through Medicaid and safety-net clinics rather than a drugmaker's program. Here's how those compare using the 2026 Federal Poverty Level of $33,000 for a family of four in the 48 contiguous states.
| Program | Income Threshold | Approx. Annual Income (Family of 4) |
|---|---|---|
| Medicaid (varies by state) | Often 138%–200% FPL for adults | ~$45,540–$66,000 |
| 340B sliding-scale clinics | Clinic-specific, often up to 200% FPL for the deepest discount | Up to ~$66,000 |
| Discount cards (GoodRx, SingleCare, Inside Rx) | Not income-based | Available to anyone regardless of income |
If you're on Medicare, check our Medicare Part D guide and Extra Help (LIS) guide to see how a pharmacy or manufacturer switch could affect your plan's formulary tier for stimulant medications.
Covered Medications: Brand, Generic, and Alternatives
| Medication | Affected by This Recall? | Typical Coverage |
|---|---|---|
| Lannett generic Adderall XR, 5 mg, Lot 25285401A | Yes — this recall | Should not be dispensed until replaced |
| Lannett generic Adderall XR, other lots and strengths | No | Unaffected; normal insurance and cash pricing rules apply |
| Generic Adderall XR from other manufacturers | No | Unaffected; may require a new prescription if switching manufacturers |
| Brand Adderall XR | No | Unaffected; typically higher cash price than generic |
| Mydayis (amphetamine extended-release) | No | Unaffected; separate formulation, may need new prior authorization |
Application Process for Each Assistance Option
| Option | How to Apply |
|---|---|
| Recall replacement from your pharmacy | Call your pharmacy directly; no application needed, just your existing prescription |
| GoodRx / SingleCare / Inside Rx | Free sign-up online or via app; present the coupon or card at the pharmacy counter |
| Medicaid | Apply through your state Medicaid agency or Healthcare.gov if not yet enrolled |
| 340B community health center | Schedule an appointment at a qualifying clinic and ask about their sliding-fee scale |
Never pay extra out of pocket for a recall-related replacement. A straightforward exchange of an affected bottle for an unaffected one should not cost you anything beyond what you'd normally pay for that fill. If a pharmacy tries to charge a new, higher copay for a pure lot swap, ask them to check with their claims department before you pay.
Approval and Replacement Timelines
| Process | Typical Timeline |
|---|---|
| Pharmacy lot replacement (in stock) | Same day in most cases |
| Pharmacy replacement requiring reorder (shortage-affected) | A few days to a couple of weeks, depending on local supply |
| New prescription for a different manufacturer or formulation | Same day to 2 business days once your prescriber sends it |
| Prior authorization for an alternative stimulant | 3–14 business days depending on your plan |
Renewal and Ongoing Monitoring
- Once your bottle is replaced, there's no special renewal process — your normal refill schedule continues as before.
- If you switch manufacturers to avoid a shortage-affected product, ask your prescriber to note the preferred manufacturer on future prescriptions if your pharmacy can accommodate it.
- Check the lot number on every refill from a manufacturer with a recent recall history, at least until you've filled a few cycles without issue.
- Sign up for FDA MedWatch alerts if you want to be notified directly about future recalls affecting medications you take.
Pros and Cons of Your Replacement Options
Pros
- A straightforward lot replacement from your existing pharmacy is usually free, fast, and requires no new paperwork
- Discount cards can meaningfully lower your cost if you end up needing to fill at a different pharmacy or with a different manufacturer
- 340B clinics and Medicaid coverage exist independent of any single manufacturer's recall history
- Catching this early, before you've taken many doses from the affected lot, limits how much it affects your day-to-day functioning
Cons
- The ongoing stimulant shortage can slow down a replacement fill if your pharmacy doesn't have alternate stock on hand
- Switching manufacturers sometimes means a new prior authorization, even for the same drug and strength
- Insurance formularies don't always let you request a specific generic manufacturer by name
- Some patients notice subtle differences in how different generic manufacturers' extended-release formulations feel, even when the active ingredient is identical
Common Mistakes That Make This Worse
- Assuming this recall applies to all Adderall XR, and stopping a working, unaffected medication out of caution.
- Taking an extra dose to compensate for a "weak" capsule instead of checking the lot number first.
- Waiting until you're completely out of medication before calling your pharmacy about a replacement.
- Throwing away the affected bottle before your pharmacy or prescriber asks you to bring it in, if they need it for their own recall documentation.
- Assuming a mislabeled ER-to-IR mix-up is the same issue as a shortage-driven stockout — they're different problems that sometimes require different fixes.
- Not reporting a significant adverse reaction because it seems like a minor inconvenience rather than something worth documenting.
Real Examples: How Patients Are Handling This
Example 1 — Parent of a school-age child: A parent notices their child's teacher reporting afternoon focus problems that hadn't been an issue in months. Checking the pharmacy bottle turns up a lot number matching the recall. The pharmacy swaps the bottle same-day, and the afternoon symptoms resolve within a few days of switching back to properly functioning ER capsules.
Example 2 — Adult with a driving-heavy job: An adult patient who drives for work notices unusually early fatigue on a specific week. After checking the lot number and confirming a match, they hold off on driving until they've picked up a replacement fill, and mention the incident to their prescriber at their next visit.
Example 3 — Patient whose bottle doesn't match: A patient who saw the recall headline checks their bottle, finds a different lot number entirely, and continues their regimen as normal — a useful reminder that hearing about a recall and being affected by it are two different things.
How This Fits Into the Ongoing Adderall Shortage
This recall lands in the middle of a national stimulant shortage that has run, on and off, since October 2022. As of mid-2026, Adderall and its generics remain on the FDA's drug shortage list, with availability varying significantly by strength, manufacturer, and region. That context matters here for one practical reason: if your pharmacy needs to replace a recalled bottle and doesn't have another lot of the same strength on hand, the shortage can make that replacement take longer than it would in a normal supply environment.
If you're dealing with both this recall and a hard time finding your usual strength in stock, our Adderall shortage guide covers which strengths are hit hardest right now, how to check real-time pharmacy availability, and what to discuss with your prescriber if you need a temporary bridge plan.
Bottom Line
This is a real, FDA-confirmed recall, but a narrow one: one lot, one strength, one manufacturer, Class II severity. If your bottle's lot number is 25285401A, call your pharmacy today and get it swapped. If it isn't, your medication isn't part of this recall, and the smartest thing you can do is bookmark the lot number so you can double-check it on your next refill too.
The bigger lesson here applies beyond this single recall: extended-release stimulants depend entirely on a manufacturing process working correctly, and a labeling slip can turn a 12-hour medication into a 4-hour one without any visible difference in the pill itself. Checking your lot number against active recalls each time you refill is a small habit that costs nothing and catches exactly this kind of problem early.